查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571566

免疫沉淀市场规模、份额和趋势分析报告：按产品类型、最终用途、地区和细分市场预测，2024-2030 年

Immunoprecipitation Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Type, By End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

免疫沉淀市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球免疫沉淀市场规模预计将达到 11 亿美元。

预计2024年至2030年该市场将以5.7%的复合年增长率成长。生命科学领域的成长预计将推动市场。免疫沉淀技术的技术进步也导致了高需求。

免疫沉淀分析法透过将抗体与蛋白质结合，使目标蛋白质从溶液中沉淀出来。该技术可以从大量不同的蛋白质样本中分离和富集特定蛋白质或蛋白质复合物。生命科学产业的成长主要是由主要企业对研发领域的大量投资所推动的。 2016年，默克研发投入约2.868亿美元，支援2,000多种产品的上市。

蛋白质精製方法新产品的推出导致市场快速成长。例如，2016年，赛默飞世尔科技公司宣布了一种使用免疫沉淀-质谱技术的新抗体测试和检验方法。它的开发是为了帮助抗体製造商、研究人员和其他客户识别适合蛋白质分析的抗体。各种套件和试剂（例如抗体、珠子和缓衝液）的可用性预计将显着增加该技术的使用。

免疫沉淀市场报告亮点

  • 试剂产品领域在免疫沉淀市场占据主导地位，2023年销售份额为53.9%。试剂部分以抗体为主，广泛应用于各种免疫沉淀技术。
  • 个别蛋白质免疫沉淀类型主导免疫沉淀市场，2023 年收益占有率为 28.6%。
  • 在研发投资以及政府津贴、捐赠和私人组织资金不断增加的推动下，学术和研究机构细分市场在免疫沉淀市场占据主导地位，2023 年收益占有率为 45.1%。
  • 北美免疫沉淀市场主导全球免疫沉淀市场，2023年收益占有率为36.7%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章免疫沉淀市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 免疫沉淀市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 免疫沉淀市场：产品评估与趋势分析

  • 细分仪表板
  • 免疫沉淀市场：2023 年和 2030 年产品变异分析
  • 套件
  • 试剂

第五章免疫沉淀市场：类型估计和趋势分析

  • 细分仪表板
  • 免疫沉淀市场：类型变异分析，2023 年和 2030 年
  • 个体蛋白免疫沉淀
  • 蛋白质复合物免疫沉淀
  • 染色质免疫沉淀
  • 核糖核蛋白免疫沉淀分析法
  • 标记蛋白的免疫沉淀

第六章免疫沉淀市场：最终用途估计与趋势分析

  • 细分仪表板
  • 免疫沉淀市场：2023 年和 2030 年最终用途变化分析
  • 学术研究所
  • 製药和生物技术公司
  • 委託研究组织

第七章免疫沉淀市场：区域估计与趋势分析

  • 2023 年及 2030 年免疫沉淀市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Abcam Limited
    • BioLegend, Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript
    • Merck KGaA
    • Novus Biologicals
    • Takara Bio Inc.
    • Biologics International Corp
简介目录
Product Code: GVR-4-68038-017-0

Immunoprecipitation Market Growth & Trends:

The global immunoprecipitation market size is anticipated to reach USD 1.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2024 to 2030. Growth of the life science sector is expected to drive the market. Technological advancements in immunoprecipitation techniques is another factor contributing to high demand.

Immunoprecipitation helps precipitate target protein from a solution by binding an antibody to that protein. This technique allows isolation and concentration of a particular protein or protein complex out of a sample of numerous different proteins. Growth in the life science industry is rising mainly due to significant investments made in the R&D sector by key players. In 2016, Merck invested around USD 286.8 million in R&D, which supported their launch of over 2,000 products.

Introduction of novel products in protein purification methods has led to rapid growth in the market. For instance, in 2016, Thermo Fisher Scientific introduced a new antibody testing and verification methodology by using Immunoprecipitation-Mass Spectrometry technique. This is developed in order to assist antibody manufacturers, researchers, and other customers in identifying a suitable antibody for protein analysis. Availability of varied kits and reagents, such as antibodies, beads, and buffers is expected to increase the adoption of this technique to a great extent.

Immunoprecipitation Market Report Highlights:

  • The reagents product segment dominated the immunoprecipitation market with a revenue share of 53.9% in 2023. The reagents segment is dominated by antibodies, which are used extensively for various immunoprecipitation techniques.
  • The individual protein immunoprecipitation type segment dominated the immunoprecipitation market with a revenue share of 28.6% in 2023.
  • The academic & research institutes segment dominated the immunoprecipitation market with a revenue share of 45.1% in 2023, fueled by increased R&D investments and funding from government grants, donations, and private organizations.
  • North America immunoprecipitation market dominated the global immunoprecipitation market with a revenue share of 36.7% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoprecipitation Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Immunoprecipitation Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunoprecipitation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Immunoprecipitation Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Antibodies
      • 4.4.2.1. Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Beads
      • 4.4.3.1. Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunoprecipitation Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Immunoprecipitation Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Individual Protein Immunoprecipitation
    • 5.3.1. Individual Protein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Protein Complex Immunoprecipitation
    • 5.4.1. Protein Complex Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Chromatin Immunoprecipitation
    • 5.5.1. Chromatin Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Ribonucleoprotein Immunoprecipitation
    • 5.6.1. Ribonucleoprotein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tagged Proteins Immunoprecipitation
    • 5.7.1. Tagged Proteins Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunoprecipitation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Immunoprecipitation Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Contract Research Organizations
    • 6.5.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunoprecipitation Market: Regional Estimates & Trend Analysis

  • 7.1. Immunoprecipitation Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/Strategic Initiatives
    • 8.4.2. Abcam Limited
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/Strategic Initiatives
    • 8.4.3. BioLegend, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/Strategic Initiatives
    • 8.4.4. Bio-Rad Laboratories, Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/Strategic Initiatives
    • 8.4.5. GenScript
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/Strategic Initiatives
    • 8.4.6. Merck KGaA
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/Strategic Initiatives
    • 8.4.7. Novus Biologicals
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/Strategic Initiatives
    • 8.4.8. Takara Bio Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/Strategic Initiatives
    • 8.4.9. Biologics International Corp
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/Strategic Initiatives